PNAS. CNIO researchers clarify the role of the two isoforms of KRAS, the most common oncogene in human cancer

by CNIO - Centro Nacional de Investigaciones Oncológicas

KRAS was one of the first oncogenes to be identified, a few decades ago. It is among the most common drivers of cancer and its mutations can be detected in around 25 per cent of human tumours. The dev...

Read more

CNIO researchers develop an effective strategy to induce regression in lung tumours caused by the KRAS oncogene in mice

by CNIO - Centro Nacional de Investigaciones Oncológicas

Researchers from the Experimental Oncology Group at the CNIO have achieved complete remission of 25% of lung tumours caused by the KRAS oncogene in mice by inactivating CDK4 and RAF1, two genes that a...

Read more

CNIO researchers find a potential therapy for the most aggressive type of lung cancer in preclinical models

by CNIO - Centro Nacional de Investigaciones Oncológicas

The specific combination of the drugs dasatinib and demcizumab impairs the growth of KRAS-driven lung tumours, the most aggressive sub-type and with the lowest survival rates

Read more
Subscribe to Directory
Write an Article

Recent News

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

A preclinical trial shows the effectiven...

by Fundació Clínic per a la Recerca Biomèdica

Researchers at IDIBAPS-Hospital Clínic Barcelona show that the admini...

Photos Stream